| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Saleh Ibrahim | Q43139623 |
| P2093 | author name string | Manfred Kunz | |
| P2860 | cites work | Reliability and reproducibility issues in DNA microarray measurements | Q24289394 |
| IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production | Q24338636 | ||
| IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis | Q24563235 | ||
| The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements | Q24597089 | ||
| Cluster analysis and display of genome-wide expression patterns | Q24644463 | ||
| Psoriasis pathophysiology: current concepts of pathogenesis | Q24674984 | ||
| Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris | Q24676186 | ||
| Evaluation of gene expression measurements from commercial microarray platforms | Q24682668 | ||
| Identification of multiple cell cycle regulatory functions of p57Kip2 in human T lymphocytes | Q40528382 | ||
| Expression of cytokine- and chemokine-related genes in peripheral blood mononuclear cells from lupus patients by cDNA array | Q40653988 | ||
| Exacerbations of multiple sclerosis in patients treated with gamma interferon | Q40797798 | ||
| Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with rheumatoid arthritis | Q40942545 | ||
| The probable role of interferon in allergy | Q41073556 | ||
| Scleroderma bronchoalveolar lavage fluid contains thrombin, a mediator of human lung fibroblast proliferation via induction of platelet-derived growth factor alpha-receptor | Q41479307 | ||
| Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction | Q41927546 | ||
| Immunoregulatory role of interleukin 10 in rheumatoid arthritis | Q42942352 | ||
| Early molecular and cellular events of oxidant-induced pulmonary fibrosis in rats | Q43507051 | ||
| Gene-expression profile of collagen-induced arthritis | Q43927636 | ||
| Anticytokine therapy--new approach to the treatment of autoimmune and cytokine-disturbance diseases | Q44225152 | ||
| Gene expression profiling of relevant biomarkers for treatment evaluation in multiple sclerosis | Q44956142 | ||
| Antigen microarray profiling of autoantibodies in rheumatoid arthritis. | Q46107435 | ||
| Autoantigen microarrays for multiplex characterization of autoantibody responses | Q46316594 | ||
| Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes | Q46512140 | ||
| Cytokine profile and proteome analysis in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis | Q47834518 | ||
| Immunosuppressive Effect of an Anti-interferon Serum | Q47882508 | ||
| Human lupus T cells resist inactivation and escape death by upregulating COX-2. | Q48022316 | ||
| Expression profiling identifies responder and non-responder phenotypes to interferon-beta in multiple sclerosis. | Q48301171 | ||
| A controlled trial of natalizumab for relapsing multiple sclerosis | Q48414534 | ||
| Characterization of MRI response to treatment with interferon beta-1b: contrast-enhancing MRI lesion frequency as a primary outcome measure | Q48625303 | ||
| Gene expression profiling of the nervous system in murine experimental autoimmune encephalomyelitis | Q48779162 | ||
| A rapid method for computationally inferring transcriptome coverage and microarray sensitivity. | Q50769448 | ||
| Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. | Q50850177 | ||
| Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabète Insuline Orale group. | Q51554328 | ||
| In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin. | Q51985338 | ||
| Increased expression of Wnt5a in psoriatic plaques. | Q52931634 | ||
| Psoriasis: a possible risk factor for development of coronary artery calcification. | Q53504190 | ||
| Genetic linkage analysis of collagen-induced arthritis in the mouse. | Q54117646 | ||
| Function of interleukin-20 as a proinflammatory molecule in rheumatoid and experimental arthritis. | Q54584374 | ||
| Gene expression profiles in psoriasis: analysis of impact of body site location and clinical severity. | Q54674355 | ||
| Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. | Q55049410 | ||
| Genetic variants in the tumor necrosis factor receptor II gene in patients with multiple sclerosis | Q59273858 | ||
| Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies | Q61647750 | ||
| Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, | Q67543574 | ||
| Autoimmune Phenomena in Patients with Malignant Carcinoid Tumors During Interferon-α Treatment | Q67918972 | ||
| Serum interferon levels in patients with systemic lupus erythematosus | Q72664589 | ||
| Quantitative genetic variation in CD19 expression correlates with autoimmunity | Q73209385 | ||
| Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray | Q73283436 | ||
| High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism | Q73458527 | ||
| Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions | Q24793110 | ||
| Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin | Q24817058 | ||
| Expression monitoring by hybridization to high-density oligonucleotide arrays | Q27860473 | ||
| A comparison of normalization methods for high density oligonucleotide array data based on variance and bias | Q27860710 | ||
| Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease | Q28140475 | ||
| Nonsteroidal anti-inflammatory drugs in systemic lupus erythematosus | Q28182127 | ||
| Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus | Q28212039 | ||
| Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17 | Q28213628 | ||
| IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells | Q28214882 | ||
| Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis | Q28239197 | ||
| The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation | Q28266133 | ||
| Gene expression analysis of interferon-beta treatment in multiple sclerosis | Q28276381 | ||
| Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1) | Q28280453 | ||
| Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2) | Q28280465 | ||
| Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation | Q29614224 | ||
| Interferon and granulopoiesis signatures in systemic lupus erythematosus blood | Q29615064 | ||
| Microarray data normalization and transformation | Q29617789 | ||
| Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis | Q29620481 | ||
| Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis | Q29620506 | ||
| Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus | Q30828464 | ||
| Molecular subsets in the gene expression signatures of scleroderma skin | Q33354088 | ||
| The pathogenesis of psoriasis: immunological facts and speculations | Q33542328 | ||
| Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis | Q33862720 | ||
| Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group | Q33885648 | ||
| The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. | Q33936389 | ||
| The promise of transcription profiling for understanding the pathogenesis of scleroderma | Q34109157 | ||
| Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli | Q34380241 | ||
| B-cell targeting in rheumatoid arthritis and other autoimmune diseases | Q34514813 | ||
| Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate | Q34547988 | ||
| Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION). | Q34585521 | ||
| Triggering psoriasis: the role of infections and medications | Q34714632 | ||
| Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial | Q34764081 | ||
| Identification of blood biomarkers of rheumatoid arthritis by transcript profiling of peripheral blood mononuclear cells from the rat collagen-induced arthritis model | Q34896648 | ||
| Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis | Q35132863 | ||
| Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein | Q73502940 | ||
| Increased concentrations of the circulating angiogenesis inhibitor endostatin in patients with systemic sclerosis | Q73678554 | ||
| Development of anti-TNF therapy for rheumatoid arthritis | Q74187188 | ||
| Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial | Q74265787 | ||
| Cutting edge: molecular portrait of human autoimmune disease | Q74334835 | ||
| Innate immunity in the etiopathology of autoimmunity | Q77297465 | ||
| Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium | Q77738643 | ||
| Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling | Q77813238 | ||
| CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis | Q78387171 | ||
| A single dose, placebo controlled study of the fully human anti-tumor necrosis factor-alpha antibody adalimumab (D2E7) in patients with rheumatoid arthritis | Q78472012 | ||
| Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice | Q79317500 | ||
| Cracking the cytokine code in psoriasis | Q79888452 | ||
| Using an advanced intercross line to identify quantitative trait loci controlling immune response during collagen-induced arthritis | Q79954717 | ||
| Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate | Q80201780 | ||
| Autoimmunity gene expression portrait: specific signature that intersects or differentiates between multiple sclerosis and systemic lupus erythematosus | Q80576940 | ||
| Identification of new quantitative trait loci in mice with collagen-induced arthritis | Q80969793 | ||
| Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus | Q81000909 | ||
| IL-1 trap go-ahead | Q81236953 | ||
| [Psoriasis, metabolic syndrome and its components] | Q81241816 | ||
| Ustekinumab for chronic plaque psoriasis | Q81295694 | ||
| Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial | Q81300604 | ||
| IFNG polymorphisms are associated with gender differences in susceptibility to multiple sclerosis | Q81326731 | ||
| Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial | Q81354813 | ||
| Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis | Q81497707 | ||
| Elevated urinary VCAM-1, P-selectin, soluble TNF receptor-1, and CXC chemokine ligand 16 in multiple murine lupus strains and human lupus nephritis | Q81550440 | ||
| Psoriasis | Q81716559 | ||
| Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis | Q94174926 | ||
| Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics | Q37211240 | ||
| Signalling, inflammation and arthritis: Crossed signals: the role of interleukin-15 and -18 in autoimmunity. | Q37214209 | ||
| Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies | Q37273372 | ||
| Genetic epidemiology: the use of old and new tools for multiple sclerosis | Q37308660 | ||
| Proteomic toolbox for autoimmunity research | Q37459220 | ||
| Peripheral blood gene expression profiling in rheumatoid arthritis. | Q38324573 | ||
| Immunosuppressive therapy modulates T lymphocyte gene expression in patients with systemic lupus erythematosus | Q38337735 | ||
| Blood cell gene expression profiling in rheumatoid arthritis. Discriminative genes and effect of rheumatoid factor | Q38340814 | ||
| Rheumatoid arthritis is a heterogeneous disease: evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues | Q38351694 | ||
| Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array | Q38356616 | ||
| Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. | Q38410039 | ||
| Classification analysis of the transcriptosome of nonlesional cultured dermal fibroblasts from systemic sclerosis patients with early disease | Q38520839 | ||
| Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies | Q40273508 | ||
| Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study | Q40377079 | ||
| Gene expression profiling of peripheral blood mononuclear leukocytes from psoriasis patients identifies new immune regulatory molecules. | Q40401838 | ||
| ??? | Q28295371 | ||
| Preliminary results of safety and efficacy of the interleukin 1 receptor antagonist anakinra in patients with severe lupus arthritis. | Q35555391 | ||
| Rituximab: expanding role in therapy for lymphomas and autoimmune diseases | Q35640302 | ||
| The use of microarrays to study autoimmunity. | Q35660715 | ||
| Microarray analysis of interferon-regulated genes in SLE. | Q35675519 | ||
| Initiation of autoimmunity. | Q35931561 | ||
| Emerging approaches for the therapy of autoimmune and chronic inflammatory disease | Q35931579 | ||
| Genetics of human systemic lupus erythematosus: the emerging picture | Q35931590 | ||
| Gene expression profiling in the study of the pathogenesis of systemic lupus erythematosus | Q35952032 | ||
| Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines | Q35953412 | ||
| Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab | Q35954629 | ||
| Psoriasis: emerging therapeutic strategies | Q36028220 | ||
| An array of possibilities for the study of autoimmunity | Q36148412 | ||
| The genetics of psoriasis and autoimmunity | Q36241637 | ||
| Interferon pathway activation in systemic lupus erythematosus | Q36319618 | ||
| Systemic and cell type-specific gene expression patterns in scleroderma skin | Q36349808 | ||
| Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice | Q36370602 | ||
| Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade | Q36403583 | ||
| Gene expression profiling in human autoimmunity. | Q36453363 | ||
| Proteomic biomarkers for autoimmune disease | Q36512336 | ||
| Genome-scale assessment of molecular pathology in systemic autoimmune diseases using microarray technology: a potential breakthrough diagnostic and individualized therapy-design tool | Q36570680 | ||
| Genetics of autoimmune neuroinflammation | Q36594360 | ||
| When T cells recognize a pattern, they might cause trouble. | Q36607729 | ||
| Systemic lupus erythematosus: all roads lead to type I interferons | Q36608558 | ||
| Immune therapies of autoimmune diseases: are we approaching a real cure? | Q36608576 | ||
| Genomics and proteomics: emerging technologies in clinical cancer research. | Q36610134 | ||
| Dissecting the genetic basis of rheumatoid arthritis in mouse models | Q36638763 | ||
| Update on cytokines in rheumatoid arthritis | Q36784047 | ||
| Signalling, inflammation and arthritis: crossed signals: the role of interleukin (IL)-12, -17, -23 and -27 in autoimmunity. | Q37073169 | ||
| Interleukin-7 in rheumatoid arthritis. | Q37115100 | ||
| At the horizon of innovative therapy in rheumatology: new biologic agents | Q37128310 | ||
| Cytokines as therapeutic targets: advances and limitations | Q37133439 | ||
| The modulatory capacity of interleukin-21 in the pathogenesis of autoimmune disease | Q37175506 | ||
| Updates on high-throughput molecular profiling for the study of rheumatoid arthritis | Q37189537 | ||
| Assessment tools in psoriatic arthritis. | Q37210192 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell biology | Q7141 |
| cytokine | Q212354 | ||
| peptide | Q172847 | ||
| autoimmunity | Q192360 | ||
| autoimmune disease | Q8084905 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 979258 | |
| P577 | publication date | 2009-10-26 | |
| P1433 | published in | Mediators of Inflammation | Q2144494 |
| P1476 | title | Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity | |
| P478 | volume | 2009 |
| Q26823326 | A cytokine-centric view of the pathogenesis and treatment of autoimmune arthritis |
| Q50074476 | A fluorescent microbead-based microfluidic immunoassay chip for immune cell cytokine secretion quantification. |
| Q91607209 | Adipose stem cells from patients with Crohn's disease show a distinctive DNA methylation pattern |
| Q87166946 | Association between calcaneus quantitative ultrasound (QUS) parameters and thyroid status in middle-aged and elderly Chinese men with euthyroidism: a population-based cross-sectional study |
| Q38932311 | B cells in chronic obstructive pulmonary disease: moving to center stage. |
| Q38675946 | Buprenorphine Alters Inflammatory and Oxidative Stress Molecular Markers in Arthritis. |
| Q48190297 | Butyrylcholinesterase and Acetylcholinesterase polymorphisms in Multiple Sclerosis patients: implication in peripheral inflammation. |
| Q35406486 | Caspase-8 inactivation in T cells increases necroptosis and suppresses autoimmunity in Bim-/- mice |
| Q34595652 | Cellular requirements for systemic control of Salmonella enterica serovar Typhimurium infections in mice |
| Q35617627 | Characterization of a novel and spontaneous mouse model of inflammatory arthritis |
| Q46334848 | Commensal bacterial modulation of the host immune response to ameliorate pain in a murine model of chronic prostatitis |
| Q35294424 | Cytokines in autoimmunity: role in induction, regulation, and treatment |
| Q84230230 | Detection of autoantibodies and increased concentrations of interleukins in plasma from patients with Tourette's syndrome |
| Q31121156 | Development of a spontaneous liver disease resembling autoimmune hepatitis in mice lacking tyro3, axl and mer receptor tyrosine kinases |
| Q54274575 | Different frequencies of Tc17/Tc1 and Th17/Th1 cells in chronic spontaneous urticaria. |
| Q53165602 | Early IFN-γ production together with decreased expression of TLR3 and TLR9 characterizes EAE development conditional on the presence of myelin. |
| Q37730867 | Emerging role of interleukin-22 in autoimmune diseases |
| Q42511894 | Expression of genes involved in susceptibility to multifactorial autoimmune diseases: estimating genotype effects |
| Q46649677 | Genetic variant on PDGFRL associated with Behçet disease in Chinese Han populations |
| Q33777950 | Hepatic expression profiles in retroviral infection: relevance to drug hypersensitivity risk. |
| Q33792718 | High Sensitivity Determination of TNF-α for Early Diagnosis of Neonatal Infections with a Novel and Reusable Electrochemical Sensor |
| Q87514916 | Human cathelicidin LL-37 and its derivative IG-19 regulate interleukin-32-induced inflammation |
| Q40401297 | Hyperactivation of the NLRP3 Inflammasome in Myeloid Cells Leads to Severe Organ Damage in Experimental Lupus |
| Q38824601 | Immunosensors for Biomarker Detection in Autoimmune Diseases. |
| Q50296996 | Influence of Adalimumab on the Expression Profile of Genes Associated with the Histaminergic System in the Skin Fibroblasts In Vitro. |
| Q34067524 | Inhibition of Endothelin-1 Receptors Improves Impaired Nitric Oxide Synthase-Dependent Dilation of Cerebral Arterioles in Type 1 Diabetic Rats |
| Q64102046 | Inhibitory effect of tanshinone IIA on inflammatory response in rheumatoid arthritis through regulating β-arrestin 2 |
| Q54461005 | Insights into abnormal sphingolipid metabolism in multiple sclerosis: targeting ceramide biosynthesis as a unique therapeutic strategy. |
| Q52649775 | Interleukin-37: A crucial cytokine with multiple roles in disease and potentially clinical therapy. |
| Q34128679 | Intestinal barrier dysfunction develops at the onset of experimental autoimmune encephalomyelitis, and can be induced by adoptive transfer of auto-reactive T cells |
| Q55235030 | Meta-analyses of IL1A polymorphisms and the risk of several autoimmune diseases published in databases. |
| Q35059964 | Molecular characterization of subcutaneous panniculitis-like T-cell lymphoma reveals upregulation of immunosuppression- and autoimmunity-associated genes |
| Q35178738 | More than just a T-box: the role of T-bet as a possible biomarker and therapeutic target in autoimmune diseases. |
| Q38653998 | PK/PD studies on non-selective PDE inhibitors in rats using cAMP as a marker of pharmacological response. |
| Q33654295 | Paradoxical effect of pertussis toxin on the delayed hypersensitivity response to autoantigens in mice |
| Q33939691 | Pathogen recognition receptor signaling accelerates phosphorylation-dependent degradation of IFNAR1 |
| Q36737168 | Pituitary adenylate cyclase-activating peptide and vasoactive intestinal polypeptide bias Langerhans cell Ag presentation toward Th17 cells |
| Q40237771 | Precision Medicine: Personalized Proteomics for the Diagnosis and Treatment of Idiopathic Inflammatory Disease. |
| Q47138584 | Regenerative Therapies in Dry Eye Disease: From Growth Factors to Cell Therapy |
| Q45342213 | Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients |
| Q34329492 | Sphingolipids in multiple sclerosis |
| Q52096273 | Sphingosine Toxicity in EAE and MS: Evidence for Ceramide Generation via Serine-Palmitoyltransferase Activation. |
| Q37749634 | Spinal cord mechanisms of chronic pain and clinical implications |
| Q93085849 | Structure-function guided modeling of chemokine-GPCR specificity for the chemokine XCL1 and its receptor XCR1 |
| Q36953054 | Systemic Administration of Proteoglycan Protects BALB/c Retired Breeder Mice from Experimental Arthritis. |
| Q35558638 | T cell subsets and their signature cytokines in autoimmune and inflammatory diseases |
| Q54333446 | TGF-β and IL-23 gene expression in unstimulated PBMCs of patients with diabetes. |
| Q34478537 | Targeting of viral interleukin-10 with an antibody fragment specific to damaged arthritic cartilage improves its therapeutic potency |
| Q26775934 | Th17 plasticity and its changes associated with inflammatory bowel disease |
| Q92923943 | The Effect of Human Recombinant Tumor Necrosis Factor Receptor-2 on Reducing Inflammatory of Collagen -Induced Arthritis in Balb/c Mice |
| Q33701615 | The Repeated Administration of Resveratrol Has Measurable Effects on Circulating T-Cell Subsets in Humans. |
| Q28077460 | The Telomere/Telomerase System in Chronic Inflammatory Diseases. Cause or Effect? |
| Q35840722 | The gene expression profile of preclinical autoimmune arthritis and its modulation by a tolerogenic disease-protective antigenic challenge |
| Q30409961 | The immunosuppressive role of adenosine A2A receptors in ischemia reperfusion injury and islet transplantation |
| Q37806610 | The multiple faces of autoimmune-mediated bone loss |
| Q34672072 | The novel phospho-non-steroidal anti-inflammatory drugs, OXT-328, MDC-22 and MDC-917, inhibit adjuvant-induced arthritis in rats |
| Q24317163 | The novel role of SERPINB9 in cytotoxic protection of human mesenchymal stem cells |
| Q37831821 | The role of Th17 lymphocytes in the autoimmune and chronic inflammatory diseases |
| Q37812002 | The role of cytokines in Guillain–Barré syndrome |
| Q55037690 | Therapeutic Potential of Pien Tze Huang on Experimental Autoimmune Encephalomyelitis Rat. |
| Q34106220 | Therapeutic Strategies for SLE Involving Cytokines: Mechanism-Oriented Therapies Especially IFN- Targeting Gene Therapy |
| Q44132017 | Vitamin D: emerging roles in infection and immunity |
Search more.